St. Cloud, MN July 21, 2004 -- NeuroMEDx, an early stage medical device company located in St. Cloud, MN, focused on the treatment of neurologic disorders, has been issued patent #6,764,498 from the United States Patent and Trademark Office. This is the second patent the company has received for implantable devices to treat disorders such as Parkinson's Disease, Epilepsy, and depression. In addition to providing an alternative to surgery and drug therapies, NeuroMEDx' MED(Mechanoelectric Device)technology may be a viable option to other device-based treatments offered by Medtronic(MDT), Cyberonics(CYBX), Advanced Neurologic Systems(ANSI), Guidant(GDT) and St. Jude(STJ). The MED technology is implanted using standard minimally invasive procedures.
The company also has patents pending that leverage the MED technology in treating disorders of the cardiac and central nervous systems.
Contact Information:
Hans Mische
1 612 987 0249
patriot@cloudnet.com
For information about antidepressant Zoloft dosage, visit
http://yourdepressioninfo.com/antidepressantzoloftdosage/
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment